AzTrials
AzTrials

Oxidative StressNCT04959006

Investigating a Natural Antioxidant Food Product on Oxidative Stress in Recreationally Active Participants

A study testing Antioxidant supplement in people with Oxidative Stress and Exercise Recovery, run by Anglia Ruskin University at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to investigate the short term use of olive extract polyphenols on markers of oxidative stress in response to acute endurance exercise in recreationally active, healthy volunteers.The study will be conducted under laboratory conditions following a 16 day supplemental period. Read more about this study

Who is it for?
Ages 21 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Oxidative Stress, Exercise Recovery
What is being tested?
Antioxidant supplement
Type of treatment
Pill or oral medicine
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
30 participants
Where
1 siteUnited Kingdom
Study dates
1 May 2021to 1 Oct 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Men and women, UK based, above 21 years of age and below 65 years of age
  • All participants: No known history (including family history) of heart abnormalities, hypertension, coronary heart disease or diabetes (determined from pre-study health screen questionnaire)
  • All participants: Not currently suffering from any musculo-skeletal injury, or any other reason that may prevent participation in cardiovascular exercise
  • All participants: Have not suffered from recent viral infections ie: influenza (defined within the prior 2 months)
  • All participants (and household members): COVID-19 related - have not suffered with any symptoms associated with Covid-19
  • All participants: Not suffering from any known blood related disorders, including blood coagulation abnormalities, or have any adverse reactions to blood taking
Show all 10Show fewer
  • All participants: Not taking any prescribed or over-the-counter medication which may influence exercise training (with the exception of inhalers for exercise induced asthma or contraceptive pill)
  • All participants: Not consuming or prepared to refrain from consumption, any commercial supplementation which conflicts with the study parameters ie: antioxidants.
  • All participants: no known allergy or intolerance to olives or prune/grape juice.
  • Baseline maximal oxygen uptake >25ml/kg/min representative of normal fitness levels (measured during pre-screening)

Who cannot join

  • Anyone below the age of 21 years or above 65 years of age
  • All participants: anyone with a known history (including family history) of heart abnormalities, hypertension, coronary heart disease or diabetes (determined from pre-study health screen questionnaire)
  • All participants: Anyone suffering from a current musculo-skeletal injury, or any other reason that may prevent participation in cardiovascular exercise
  • All participants: those suffering from recent viral infections ie: influenza (defined within the prior 2 months)
  • All participants: anyone who has (previously or currently) had any symptoms associated with covid-19 (including household members)
  • All participants: Those with known blood related disorders, including blood coagulation abnormalities, or have any adverse reactions to blood taking. This includes any participant who has or potentially has an infectious disease, inc. HIV, and all types of hepatitis.
Show all 11Show fewer
  • All participants: Anyone taking any prescribed or over-the-counter medication which may influence exercise training (with the exception of inhalers for exercise induced asthma or contraceptive pill)
  • All participants: Anyone consuming or not prepared to refrain from consumption, any commercial supplementation which conflicts with the study parameters ie: antioxidants
  • All participants: anyone with a known allergy or intolerance to olives or prune/grape juice.
  • Any not meeting the baseline criteria for maximal oxygen uptake
  • FEMALE ONLY: Any participant who is, suspects they may be or becomes pregnant during the study.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Anglia Ruskin University

    Cambridge, Cambridgeshire, CB1 1PT

Other trials in United Kingdom

About this study

Official title: Investigating the Impact of a Natural Antioxidant Food Product on Exerciseinduced Oxidative Stress in Recreationally Active Participants

The aim of this study is to investigate the short term use of olive extract polyphenols on markers of oxidative stress in response to acute endurance exercise in recreationally active, healthy volunteers.The study will be conducted under laboratory conditions following a 16 day supplemental period. Participants will be required to attend the laboratory for a pre-screening/familiarisation trial followed by assessments PRE (baseline, days 1,2) and POST intervention (days 18,19). Across the intervention, participants will maintain habitual dietary intake/ exercise training.

Additionally participants will be randomised in a double-blinded manner to either a placebo or antioxidant-rich supplementation (olive extract water).

It is hypothesised that the polyphenols (antioxidants) found within olive extract drink will enhance markers of recovery to an endurance exercise bout compared with the placebo drink.

Read the detailed description

There is current scientific interest in the use of fruit and plant-based polyphenol supplementation for exercise recovery. Current inference highlights that acute supplementation (~3d) with >1000mg polyphenols per day may enhance recovery from intensive exercise, with most focus on pomegranate, cocoa, green tea extracts, Montmorency cherry concentrate and blackcurrant food products. However, further research is needed to access impact of natural polyphenols at lower or similar doses for longer time periods (>7d) on endurance based activities and subsequent recovery.

There has also been significant clinical research interest in the properties of waste water produced when cold pressing olives, which has been shown to contain high concentrations of natural polyphenols. Fattoria La Vialla is an Italian-based organic farm producing various products including cold-pressed olive oil. In doing so, they also produce olive extract which is commercially available as 'Oliphenolia'. Whilst several clinical studies have been undertaken using this product, to date there have been no studies investigating the polyphenol potential of olive extract on exercise recovery and subsequent performance.

As such, this study proposes to investigate the short term use of olive extract polyphenols on markers of oxidative stress in response to acute endurance exercise in recreationally active, healthy volunteers. Following a study briefing and provision of written, informed consent, participants will be required to attend the Human Physiology Laboratory at Anglia Ruskin University on 5 occasions as follows:

Session 1 - assessment of metabolic responses to incremental exercise intensity and individual maximal oxygen uptake (VO2max) using a standardised treadmill-based ramp protocol. Measurement of VO2max will be required for assessment of exercise intensity for sessions 2 and 4 (see below). The treadmill protocol to be used is similar to that previously published, involving two graded exercise tests (GXT1 and GXT2). Following a 10min resting period and assessment of baseline measures (e.g. blood pressure, body composition) and a 5min warm up period, GXT1 will involve participants completing ~6 x 4min stages (3mins running, 1 minute passive recovery in which capillary blood sampling for glucose/lactate will be carried out). Starting speeds will be between ~6-10km/h (1 % gradient) with each stage involving speed increments of 1 km/h. Exercise will continue until blood lactate concentration exceeds 4 mMol/L. Following a 10 min rest, GXT 2 will begin at a speed 2 km·h-1 below the previous GXT 1 final speed, with gradient increasing by 1 % each min and continuing until volitional exhaustion. Throughout the test, breath-to-breath analysis (using a Metalyser 3B respiratory analyser) will be undertaken.

Session 2 - Having overnight fasted, and following resting measures (blood pressure, body composition via bioelectrical impedance analysis, 3x4ml blood sample), participants will complete an endurance training session (~75% VO2max for 60mins) on a treadmill. Additional wholeblood samples (3x4ml) will be collected immediately and 1hr post exercise.

Session 3 - Participants will return the next morning (overnight fasted) for a resting blood sample (3x4ml, 24 hours post exercise) and complete the same GXT1 and GXT2 tests carried out in session 1. This will be used to quantify metabolic and recovery indices.

Session 4 and 5 - following a 16 day nutrition product supplementation period, participants will return and complete exercise testing as per sessions 2 and 3.

Nutritional supplementation - all products will be supplied/certified independently via Fattoria La Vialla, Italy. Participants will be randomly assigned in a double-blinded manner to either: i) Experimental condition: 2x25ml olive extract drinks (https://www.oliphenolia.it/uk/) per day for 16 days, taken one mid-morning, one mid-afternoon between meals or ii) matched placebo (2x25ml of prune juice water).

Blood samples - wholeblood samples will be immediately centrifuged with serum allocated into separate cryovials for the analysis of: i) the main polyphenol compound- hydroxytyrosol; ii) a marker of oxidative stress (malondialdehyde, MDA) and iii) key antioxidant enzymes (catalase, superoxide dismutase) and redox status (reduced glutathione (GSH) to oxidized glutathione (GSSG) ratio).

Over the 16 day study period, there will be no dietary restrictions in place (other than following a low polyphenol diet 24 hours prior to each testing session), however participants will need to follow the allocated supplementation and maintain their training program (~3-4 run training sessions per week).

Being tested
Antioxidant supplement, Placebo
Keywords
Antioxidants, Exercise Metabolism, Exercise Nutrition

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Antioxidant supplementDietary supplement

    Also called Oliphenolia

    Short term (16d) supplementation of either the antioxidant supplement (Oliphenolia) or placebo. Participants required to consume 2x25ml drinks, one mid-morning, one mid-afternoon between meals.

  • PlaceboDietary supplement

    Placebo

Study groups in NCT04959006
Study groupRoleWhat they receive
Placebo groupPlacebo comparatorPlacebo drink - oral bolus (25ml) - colour/taste matched (prune juice/cola/tonic water, 1:1:1 ratio).
Receives: Dietary Supplement: Placebo
Antioxidant supplementExperimentalExperimental condition -oral bolus (25ml) olive extract drink(https://www.oliphenolia.it/uk/)
Receives: Dietary Supplement: Antioxidant supplement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Oxidative stress biomarker

    Blood measure of malondialdehyde, MDA (pmol/ml)

    Measured: Change from pre (day 1) to post intervention (day 18)

  2. Redox status

    Blood measure of reduced glutathione (GSH) to oxidized glutathione (GSSG) (measured in uM)

    Measured: Relative change from pre (day 1) to post intervention (day 18)

  3. Endogenous antioxidant enzyme 1

    Blood measure of catalase (mU/ml)

    Measured: Relative change from pre (day 1) to post intervention (day 18)

  4. Endogenous antioxidant enzyme 2

    Blood measure of superoxide dismutase (inhibition rate %)

    Measured: Relative change from pre (day 1) to post intervention (day 18)

  5. Hydroxytyrosol

    Blood measure of hydroxytyrosol (main active ingredient in the antioxidant supplementation, measured in ng/ml)

    Measured: Overall change from pre (day 1) to post intervention (day 18)

Secondary outcomes (6)
  1. Submaximal exercise respiratory measures

    Assessment of metabolic efficiency via respiratory measures (oxygen, carbon dioxide, both measured in L/min) during steady state exercise

    Measured: Relative change from pre (day 1) to post intervention (day 18)

  2. Maximal exercise respiratory measures

    Assessment of exercise capacity and tolerance during maximal exercise via respiratory measures (oxygen, carbon dioxide, both measured in L/min)

    Measured: Relative change from pre (day 1) to post intervention (day 18)

  3. Body mass

    Assessment of body mass (kg). Body mass and height will be combined to report Body Mass Index (BMI) in kg/m^2

    Measured: Change from pre (day 1) to post intervention (day 18)

  4. Height

    Assessment of participant height (m). Body mass and height will be combined to report Body Mass Index (BMI) in kg/m^2

    Measured: Change from pre (day 1) to post intervention (day 18)

  5. Body composition

    Assessment of bodyfat (%) used to derive lean mass (kg) based on total body mass (kg)

    Measured: Change from pre (day 1) to post intervention (day 18)

  6. Blood pressure

    Assessment of systolic and diastolic blood pressure (measured in mmHg) at rest

    Measured: Change from pre (day 1) to post intervention (day 18)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jul 2021
  2. Study start1 May 2021
  3. Primary completion1 Sep 2021
  4. Study completion1 Oct 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants randomly assigned to either placebo or antioxidant-rich olive extract in a parallel, double blind manner
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04959006
Sponsor's protocol ID
R9039
Status last verified
Feb 2022
First submitted
22 Jun 2021
Last updated
15 Feb 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Bowtell J, Kelly V. Fruit-Derived Polyphenol Supplementation for Athlete Recovery and Performance. Sports Med. 2019 Feb;49(Suppl 1):3-23. doi: 10.1007/s40279-018-0998-x.

    PubMed 30671906
  • Fisher-Wellman K, Bloomer RJ. Acute exercise and oxidative stress: a 30 year history. Dyn Med. 2009 Jan 13;8:1. doi: 10.1186/1476-5918-8-1.

    PubMed 19144121
  • Bloomer RJ, Goldfarb AH, McKenzie MJ. Oxidative stress response to aerobic exercise: comparison of antioxidant supplements. Med Sci Sports Exerc. 2006 Jun;38(6):1098-105. doi: 10.1249/01.mss.0000222839.51144.3e.

    PubMed 16775552
  • James CA, Richardson AJ, Watt PW, Gibson OR, Maxwell NS. Physiological responses to incremental exercise in the heat following internal and external precooling. Scand J Med Sci Sports. 2015 Jun;25 Suppl 1:190-9. doi: 10.1111/sms.12376.

    PubMed 25943670

Questions about this trial

What is this clinical trial studying?

A study testing Antioxidant supplement in people with Oxidative Stress and Exercise Recovery, run by Anglia Ruskin University at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Feb 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Oxidative stress biomarker (time frame: Change from pre (day 1) to post intervention (day 18)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04959006, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Feb 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in